JonathanDFishMD

PubMed

• 855 citations
  Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo
  Michael C. Milone, Jonathan D. Fish, Carmine Carpenito, Richard G. Carroll, Gwendolyn K. Binder
  Molecular Therapy. 2009-08-01
• 43 citations
  Noninvasive bioluminescent imaging of primary patient acute lymphoblastic leukemia: a strategy for preclinical modeling.
  David M. Barrett, Alix E. Seif, Carmine Carpenito, David T. Teachey, Jonathan D. Fish
  Blood. 2011-10-13
• 35 citations
  A caution regarding the use of low-molecular weight heparin in pediatric otogenic lateral sinus thrombosis.
  Udayan K. Shah, Tracey Jubelirer, Jonathan D. Fish, Lisa Elden
  International Journal of Pediatric Otorhinolaryngology. 2007-02-01

Journal Articles

• Arterial Stiffness in Childhood Cancer Survivors  
  Krystal JI, Reppucci M, Mayr T, Fish JD and Sethna C, Pediatr Blood Cancer, 1/1/2015
• Fertility Preservation for Adolescent Women with Cancer  
  Fish JD, AMSTARs. Adolesc Med, 1/1/2012
• reproducible method for non-invasive bioluminescent imaging of primary patient acute lymphoblastic leukemia: a strategy for pre-clinical modeling  
  Barrett DM, Seif AE, Carpentino C, Teachey DT, Fish JD, June CH, Grupp SA, and Reid GS, Blood, 1/1/2011
• Autologous and Allogeneic Cellular Therapies for High-Risk Pediatric Solid Tumors  
  Barrett D, Fish JD and Grupp SA, Pediatr Clin N Am, 1/1/2010
• Challenges in the use of allogeneic hematopoietic stem cell transplantation for ectodermal dysplasia with immune deficiency  
  Fish JD, Duerst RE, Gelfand EW, Quinones R, Orange J, and Bunin N, BMT, 1/1/2009
• Health Insurance for Survivors – a Pre-Existing Problem  
  Fish JD and Ginsberg J, Pediatr Blood Cancer, 1/1/2009
• mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemia (ALL)  
  Teachey D, Sheen C, Hall J, Ryan T, Brown VI, Fish J, Reid GSD, Seif AE, Norris R, Chang YJ, Carroll M and Grupp SA, Blood, 1/1/2008
• Stem cell transplantation for neuroblastoma  
  Fish JD and Grupp SA, BMT, 1/1/2008
• A caution regarding the use of low-molecular weight heparin in pediatric otogenic lateral sinus thrombosis  
  Shah U, Jubelirer T, Fish J and Elden L, International Journal of Pediatric Otorhinolaryngology, 1/1/2007
•  
  Brown VI, Hulitt J, Fish J, Sheen C, Bruno M, Xu Q, Carroll M, Fang J, Teachey D and Grupp SA, Cancer Research, 1/1/2007
• Fibroblast growth factor-2 potentiates vascular smooth muscle cell migration to platelet derived growth factor; upregulation of alpha2Beta1 integrin and disassembly of...  
  Pickering JG, Uniyal S, Ford CM, Chau T, Laurin MA, Chow LH, Ellis CG, Fish J, Chan BMC, Circulation Research, 1/1/1997
• Join now to see all

Abstracts/Posters

• PI-103, a dual inhibitor of mTOR and PI3kinase, potentiates rapamycin-mediated ALL cell death and inhibition of proliferation
  Fish JD, Sheen C, Hulitt J, Grupp SA and Brown VI, Pediatric Blood and Cancer; American Society of Pediatric Hematology Oncology Annual Meeting, 1/1/2008
• Targeting of ALL by lentivirus engineered primary human T cells
  Fish JD, Milone M, Carpenito C, Lakhal M, Ofori E, Danet-Desnoyers G, Riley J, Grupp SA and June C, Pediatric Blood and Cancer; American Society of Pediatric Hematology Oncology Annual Meeting, 1/1/2007
• PI3-Kinase inhibition induces ALL cell death, potentiates rapamycin, and prevents IL-7 mediated resistance to rapamycin
  Fish JD, Sheen C, Bruno M, Hulitt J, Grupp SA and Brown VI, Pediatric Blood and Cancer; American Society of Pediatric Hematology Oncology Annual Meeting, 1/1/2007
• PI3-Kinase Inhibition Decreases the Proliferation of ALL Cells, Potentiates mTOR Inhibition, and Abrogates Growth Factor-Mediated Reversal of mTOR Inihibition
  Fish J, Hulitt J, Bruno M, Grupp SA, and Brown VI, Blood; American Society of Hematology Annual Meeting, 1/1/2006
• Chimeric Immunoreceptor (T-Body) Targeting of Acute B-Cell Lymphoblastic Leukemia (B-ALL) through Lentivirus Engineering of Primary Human T Cells
  Milone MC, Fish J, Carpenito C, Lakal M, Ofori E, Danet-Desnoyers G, Riley JL, Grupp SA, and June CH, Blood; American Society of Hematology Annual Meeting, 1/1/2006
• Join now to see all

Lectures

• Arterial Stiffness in Childhood Cancer Survivors 
  1/1/2015
• Costs of Screening of Childhood Cancer Survivors 
  1/1/2015
• Adherence to Screening Recommendations Among Survivors of Childhood Cancer 
  1/1/2015
• Therapeutic Phlebotomy for Iron Overload in Childhood Cancer Survivors 
  1/1/2014
• Iron Overload in Long-Term Survivors of Childhood Cancer 
  1/1/2012
• Iron Overload in Childhood Cancer Survivors 
  1/1/2012
• Impact of Transfusional Support for Childhood Cancer – Peering Behind the Iron Curtain 
  1/1/2011
• mTOR Inhibitors are Synergistic with Methotrexate: An Effective Combination to Both Prevent Post-HSCT Relapse of ALL and Prevent GVHD 
  1/1/2007
• Join now to see all

Other

• Bone Marrow Transplantation, Long-Term Effects 
  Fish JD, Raval GG, Mehta P, eMedicine from WebMD
  http://emedicine.medscape.com/article/989518-overview
  1/16/2009